Publications
Select the category
iSCIB1+ pivotal trial plans advancing
AACR (American Association for Cancer Research) Annual Meeting, April 2026, San Diego, California
H126: solid iSCIB1+ data underpins planned progress
FDA clears global Phase III trial for iSCIB1+
SCOPE Phase 2 Trial Data Update, ESMO December 2025
European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 10-12 December 2025 in London
No results found.
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.